Bronchoalveolar lavage: A useful method for diagnosis of some pulmonary disorders

Respiratory Care

Volumn 42, Issue 8, 1997, Pages 765-790

  Emad, Ali ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC PNEUMONITIS; ASBESTOSIS; ASTHMA; COLLAGEN DISEASE; FAT EMBOLISM; GRAFT REJECTION; HISTIOCYTOSIS X; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG CANCER; LUNG DISEASE; LUNG FIBROSIS; LUNG INFECTION; LUNG LAVAGE; LUNG PARENCHYMA; LUNG SARCOIDOSIS; RESPIRATORY DISTRESS SYNDROME; REVIEW; SILICOSIS;

EID: 0030855306     PISSN: 00989142     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (471)

1. Daniele RP, Elias JA, Epstein PE, Rossman MD. Bronchoalveolar lavage: role in pathogenesis, diagnosis, and management of interstitial lung diseases. Ann Intern Med 1985;102(1):93-108.
2. Crystal RG, Reynolds HY, Kalica AR. Bronchoalveolar lavage. The report of an international conference. Chest 1986;90(1):122-131.
3. Reynolds HY, Newball HH. Fluid and cellular milieu of the human respiratory tract, Immunologic and infectious reactions in the lung. Volume I. Kirkpatrick CH, Reynolds HY, editors. New York: New York and Basel, Marcel Decker; 1976:3-27.
4. Debeljak A, Mermolja M, Sorli J, Zupancic M, Zorman M, Remskar J. Bronchoalveolar lavage in the diagnosis of peripheral primary and secondary malignant lung tumors. Respiration 1994;61(4):226-230.
5. Kahn FW, Jones JM. Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis 1987;155(5):862-869.
6. Diaz P, Galleguillos FR, Gonzales MC, Pantin CF, Kay AB. Bronchoalveolar lavage in asthma. J Allergy Clin Immunol 1984;74(1): 41-48.
7. Rennard SI, Thompson AB, Floreani AA. Bronchoalveolar lavage in the study of asthma [editorial]. Chest 1992;102(1): 1-2.
8. Fein A, Wiener-Kronish JP, Niederman M, Matthay MA. Pathophysiology of the adult respiratory distress syndrome. What have we learned from human studies? Crit Care Clin 1986;2(3):429-453.
9. Idell S, Cohen AB. Bronchoalveolar lavage in patients with the adult respiratory distress syndrome. Clin Chest Med 1985;6(3):459-471.
10. White DA. Pulmonary infection in the immunocompromised patient. Semin Thorac Cardiovasc Surg 1995;7(2):78-87.
11. Chastre J, Fagon JY, Soler P, Bornet M, Domart Y, Trouillet JL, et al. Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. Am J Med 1988; 85(4):499-506.
12. Stover DE, White DA, Romano PA, Gellene RA. Diagnosis of pulmonary disease in acquired immune deficiency syndrome (AIDS). Role of bronchoscopy and bronchoalveolar lavage. Am Rev Respir Dis 1984;130(4):659-662.
13. Regelmann W, Elliot G. Bronchoalveolar lavage. In: Hilman B, ed. Pediatric respiratory disease. Philadelphia: WB Saunders; 1993: 116-122.
14. Crystal RG, Gadek JE, Ferrans VJ, Fulmer JD, Line BR, Hunninghake GW. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med 1981;70(3):542-568.
15. Greening AP. Bronchoalveolar lavage [editorial]. Br Med J Clin Res Ed 1982;284(6333):1896-1897.
16. American Thoracic Society. Medical Section of the American Lung Association. Guidelines for fiberoptic bronchoscopy in adults. Am Rev Respir Dis 1987;1361066.
17. American Association for Respiratory Care. Clinical practice guideline: fiberoptic bronchoscopy assisting. Respir Care 1993;38(11): 1173-1178.
18. Low RB, David GS, Giancola MS. Biochemical analysis of bronchoalveolar lavage fluids of healthy human volunteer smokers and nonsmoker. Am Rev Respir Dis 1978;118:863-875.
19. Furth RV. Origin and kinetics of monocytes and macrophages. Semin Hematology 1970;7:125-141.
20. Merchant RK, Schwartz DA, Helmers RA, Dayton CS, Hunninghake GW. Bronchoalveolar lavage cellularity. The distribution in normal volunteers. Am Rev Respir Dis 1992;146(2):446-453.
21. Reynolds HY. Bronchoalveolar lavage. Am Rev Respir Dis 1987;135 (1):250-263.
22. Midulla F, Villani A, Merolla R, Bjermer L, Sandstrom T, Ronchetti R. Bronchoalveolar lavage studies in children without parenchymal lung disease: cellular constituents and protein levels. Pediatr Pulmonol 1995;20(2):112-118.
23. Riedler J, Grigg J, Stone C, Tauro G, Robertson CF. Bronchoalveolar lavage cellularity in healthy children. Am J Respir Crit Care Med 1995;152(1):163-168.
24. Cohen AB, Gold WM. Defense mechanisms of the lungs. Annu Rev Physiol 1975;37:325-350.
25. Gadek JE, Hunninghake GW, Zimmerman R, Kelman J, Fulmer J, Crystal RG. Pathogenetic studies in idiopathic pulmonary fibrosis. Control of neutrophil migration by immune complexes. Chest 1979; 75(Suppl): 264S-265S.
26. Golde DW, Finley TN, Cline MJ. Production of colony-stimulating factor by human macrophages. Lancet 1972;2 (792): 1397-1399.
27. Cohen AB. Interrelationships between the human alveolar macrophage and alpha-1-antitrypsin. J Clin Invest 1973;52(11):2793-2799.
28. Bienenstock J, Johnston N, Percy DY. Bronchial lymphoid tissue. I. Morphologic characteristics. Lab Invest 1973;28(6):686-692.
29. Reynolds HY, Chrétien J. Respiratory tract fluids: analysis of content and contemporary use in understanding lung diseases. Dis Mon 1984;30(5):1-103.
30. Hunninghake GW, Gadek JE, Kawanami O, Ferrans VJ, Crystal RG. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol 1979;97 (1):149-206.
31. Bell DY, Haseman JA, Spock A, McLennan G, Hook GE. Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers. Am Rev Respir Dis 1981;124(1):72-79.
32. Shasby DM, Shasby SS. Active transendothelial transport of albumin: interstitium to lumen. Circ Res 1985;57(6):903-908.
33. Warr GA, Martin RR, Sharp PM, Rossen RD. Normal human bronchial immunoglobulins and proteins: effects of cigarette smoking. Am Rev Respir Dis 1977;116(1):25-30.
34. Rennard SI, Basset SI, Lecossier D, O'Donnell KM, Martin PG, Pinkston P, Crystal RG. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986;60(2):532-538.
35. Falk GA, Okinaka AJ, Siskind GW. Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1972;105(1):14-21.
36. Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG. Analysis of cellular and protein content of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1977;59(1):165-175.
37. Reynolds HY, Newball HH. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 1974;84(4):559-573.
38. Denis M, Bedard M, Laviolette M, Cormier Y. A study of monokine release and natural killer activity in the bronchoalveolar lavage of subjects with farmer's lung. Am Rev Respir Dis 1993;147(4):934-939.
39. Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T-lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983;308(14):793-800.
40. Hinman LM, Stevens CA, Matthay RA, Gee JB. Angiotensin convertase activities in human alveolar macrophages: effects of cigarette smoking and sarcoidosis. Science 1979;205(4402):202-203.
41. Janoff A, Rajú L, Dearing R. Levels of elastase activity in bronchoalveolar lavage fluids of healthy smokers and nonsmokers. Am Rev Respir Dis 1983;127(5):540-544.
42. Koren HS, Devlin RB, Graham DE, Mann R, McGee MP, Horstman DH, et al. Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 1989;139(2):407-415.
43. Marchandise FX, Mathieu B, Francis C, Sibille Y. Local increase of antiprotease and neutrophil elastase-alpha 1-proteinase inhibitor complexes in lung cancer. Eur Respir J 1989;2(7):623-629.
44. Schmekel B, Hornblad Y, Linden M, Sundstrom C, Venge P. Myeloperoxidase in human lung lavage. II. Internalization of myeloperoxidase by alveolar macrophages. Inflammation 1990;14(4):455-461.
45. Walti H, Tordet C, Gerbaut L, Saugier P, Moriette G, Relier JP. Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: evidence for the role of nosocomial infections. Pediatr Res 1989;26(4):351-355.
46. Oslen GN, Harris JO, Castle JR, Waldman RH, Karmgard HJ. Alpha-1-antitrypsin content in the serum, alveolar macrophages, and alveolar lavage fluid of smoking and nonsmoking normal subjects. J Clinc Invest 1975;55(2):427-430.
47. Sepper R, Konttinen YT, Ding Y, Takagi M, Sorsa T. Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. Chest 1995;107(6):1641-1647.
48. Bell DY, Spock A, Hook GER. Plasma proteins of the bronchoalveolar lining from human lung. FASEB 1979;38:522.
49. Riise GC, Ahlstedt S, Larsson S, Enander I, Jones I, Larsson P, Anderson B. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 1995;50(4):360-365.
50. Kobayashi J, Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest 1995;108(2):311-315.
51. Goldstein N, Lippmann ML, Goldberg SK, Fein AM, Shapiro B, Leon SA. Usefulness of tumor markers in serum and bronchoalveolar lavage of patients undergoing fiberoptic bronchoscopy. Am Rev Respir Dis 1985;132(1):60-64.
52. Merrill WW, Goodman M, Matthay RA, Naegel GP, Vandevoorde JP, Myl AD, Reynolds HY. Quantitation of carcinoembryonic antigen in the lung lining fluid of normal smokers and nonsmokers. Am Rev Respir Dis 1981;123(1):29-31.
53. Perez T, Farre JM, Gosset P, Wallaert B, Duquesnoy B, Voisin C, et al. Subclinical alveolar inflammation in rheumatoid arthritis: superoxide anion, neutrophil chemotactic activity and fibronectin generation by alveolar macrophages. Eur Respir J 1989;2(1):7-13.
54. Hunninghake GW, Garrett KC, Richerson HB, Fantone JC, Ward PA, Rennard SI, et al. Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis 1984;130(8):476-496.
55. Song WD, Zhang AC, Pang YY, Liu LH, Zhao JY, Deng SH, Zhang SY. Fibronectin and hyaluronan in bronchoalveolar lavage fluid from young patients with chronic obstructive pulmonary diseases. Respiration 1995;62(3):125-129.
56. Grigg J, van den Borre C, Malfroot A, Pierard D, Wang D, Dab I. Bilateral fiberoptic bronchoalveolar lavage in acute unilateral lobar pneumonia. J Pediatr 1993;122(4):606-608.
57. Baughman RP, Dohn MN, Loudon RG, Frame PT. Bronchoscopy with bronchoalveolar lavage in tuberculosis and fungal infections. Chest 1991;99(1):92-97.
58. Colombo JL, Hallberg TK. Recurrent aspiration in children: lipid-laden alveolar macrophage quantitation. Pediatr Pulmonol 1987;3(2): 86-89.
59. Lieske TR, Sunderrajan EV, Passamonte PM. Bronchoalveolar lavage and technetium-99m glucoheptonate imaging in chronic eosinophilic pneumonia. Chest 1984;85(2):282-284.
60. Sutherland KR, Steinberg KP, Maunder RJ, Milberg JA, Allen DL, Hudson LD. Pulmonary infection during the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;152(2):550-556.
61. Martin RJ, Coalson JJ, Rogers RM, Horton FO, Manous LE. Pulmonary alveolar proteinosis: the diagnosis by segmental lavage. Am Rev Respir Dis 1980;121(5):819-825.
62. Strumpf IJ, Feld MK, Cornelius MJ, Keogh BA, Crystal RG. Safety of fiberoptic bronchoalveolar lavage in evaluation of interstitial lung disease. Chest 1981;80(3):268-271.
63. Springmeyer SC. The clinical use of bronchoalveolar lavage [editorial]. Chest 1987;92(5):771-772.
64. Stoller JK, Rankin JA, Reynolds HY. The impact of bronchoalveolar lavage cell analysis on clinicians' diagnostic reasoning about interstitial lung disease. Chest 1987;92(5):839-843.
65. Credle WF Jr, Smiddy JF, Elliott RC. Complications of fiberoptic bronchoscopy. Am Rev Respir Dis 1974;109(1):67-72.
66. Widdicombe JG. Reflexes from the lungs and the respiratory tract. B M Bull 1963;19:15-20.
67. Zavala DC, Godsey K, Bedell GN. The response to atropine sulfate given by aerosol and intramuscular routes to patients undergoing fiberoptic bronchoscopy. Chest 1981;79(5):512-515.
68. Pereira W, Konvat DM, Kahn MA, Jacovino JR, Spivack ML, Snider GL. Fever and pneumonia after fiberoptic bronchoscopy. Am Rev Respir Dis 1975;112:59-64.
69. Shrader DL, Lakshminarayan S. The effect of fiberoptic bronchoscopy on cardiac rhythm. Chest 1978;73(6):821-824.
70. Karetzky MS, Garvey JW, Brandstetter RD. Effect of fiberoptic bronchoscopy on arterial oxygen tension. NY State J Med 1974;74(1):62-63.
71. Lin CC, Wu JL, Huang WC. Pulmonary function in normal subjects after bronchoalveolar lavage. Chest 1988;93(5):1049-1053.
72. Krueger JJ, Sayre VA, Karetzky MS. Bronchoalveolar lavage-induced pneumothorax. Chest 1988;94(2):440-441.
73. de Fijter JW, van der Hoeven JG, Eggelmeijer F, Meinders AE. Sepsis syndrome and death after bronchoalveolar lavage. Chest 1993;104 (4):1296-1297.
74. Shepherd KE, Lynch KE, Wain JC, Brown EN, Wilson RS. Elastin fibers and the diagnosis of bacterial pneumonia in the adult respiratory distress syndrome. Crit Care Med 1995;23:1829-1834.
75. Centers for Disease Control and Prevention. Annual summary 1982: reported morbidity and mortality in the United States. MMWR Morb Mortal Wkly Rep 1983;31:110-111.
76. Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine Baltimore 1990;69(5):307-316.
77. Tew J, Calenoff L, Berlin BS. Bacterial or nonbacterial pneumonia: accuracy for radiographic diagnosis. Radiology 1977;124(3):607-612.
78. Aderaye G. The value of sputum gram stain in the diagnosis of pneumococcal pneumonia. Ethiop Med J 1994;32(3):167-171.
79. Davidson M, Tempest B, Palmer DL. Bacteriologic diagnosis of acute pneumonia. Comparison of sputum, transtracheal aspiration, and lung aspirates. JAMA 1976;235(2):158-163.
80. Jolliet P, Chevrolet JC. Bronchoscopy in the intensive care unit. Intensive Care Med 1992;18(3):160-169.
81. Baselski VS, Wunderink RG. Bronchoscopic diagnosis of pneumonia. Clin Microbiol Rev 1994;7(4):533-558.
82. Valles J, Rello J, Fernandez R, Blanch L, Baigorri F, Mestre J, et al. Role of bronchoalveolar lavage in mechanically ventilated patients with suspected pneumonia. Eur J Clin Microbiol Infect Dis 1994;13(7): 549-558.
83. Jordan GW, Wong GA, Hoeprich PD. Bacteriology of the lower respiratory tract as determined by fiberoptic bronchoscopy and transtracheal aspiration. J infect Dis 1976;134(5):428-435.
84. Worth H, Schmitz KF, Krech T, Hermeler H, Horsch R, Muller F, et al. Detection of pathogens in bronchoalveolar lavage fluid in patients with pneumonias. Prax Klin Pnuemol 1988;42(3):106-108.
85. Broughton WA, Middleton RM 3d, Kirkpatrick MB, Bass JB Jr. Bronchoscopic protected specimen brush and bronchoalveolar lavage in the diagnosis of bacterial pneumonia. Infect Dis Clin North Am 1991; 5(3):437-452.
86. Papazian L, Martin C, Meric B, Dumon JF, Gouin F. A reappraisal of blind bronchial sampling in the microbiologic diagnosis of nosocomial bronchopneumonia. A comparative study in ventilated patients. Chest 1993;103(1):236-242.
87. Cook DJ, Brun Buisson C, Guyatt GH, Sibbald WJ. Evaluation of new diagnostic technologies: bronchoalveolar lavage and the diagnosis of ventilator-associated pneumonia. Crit Care Med 1994;22(8): 1314-1322.
88. Sole-Violan J, Rodriguez de Castro F, Rey A, Martin-Gonzalez JC, Cabrera-Navarro P. Usefulness of microscopic examination of intracellular organisms in lavage fluid in ventilator-associated pneumonia. Chest 1994;106(3):889-894.
89. Somu N, Swaminathan S, Paramasivan CN, Vijayasekaran D, Chandrabhooshanam A, Vijayan VK, Prabhakar R. Value of bronchoalveolar lavage and gastric lavage in the diagnosis of pulmonary tuberculosis in children. Tuber Lung Dis 1995;76(4):295-299.
90. de Gracia J, Curull V, Vidal R, Riba A, Orriols R, Martin N, Morell F. Diagnostic value of bronchoalveolar lavage in suspected pulmonary tuberculosis. Chest 1988;93(2):329-332.
91. Pang JA, Chan HS, Chan CY, Cheung SW, French GL. A tuberculostearic acid assay in the diagnosis of sputum smear-negative pulmonary tuberculosis: A prospective study of bronchial aspirate and lavage specimens. Ann Intern Med 1989;111(8):650-654.
92. Raja A, Baughman RP, Daniel TM. The detection by immunoassay of antibody to mycobacterial antigens and cycobacterial antigens in bronchoalveolar lavage fluid from patients with tuberculosis and control subjects. Chest 1988;94(1):133-137.
93. Martin WJ 2d, Smith TF. Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method. J Clin Microbiol 1986;23(6):1006-1008.
94. Paradis IL, Grgurich WF, Dummer JS, Dekker A, Dauber JH. Rapid detection of cytomegalovirus pneumonia from lung lavage cells. Am Rev Respir Dis 1988;138(3):697-702.
95. Woods GL, Thompson AB, Rennard SL, Linder J. Detection of cytomegalovirus in bronchoalveolar lavage specimens. Spin amplification and staining with a monoclonal antibody to the early nuclear antigen for diagnosis of cytomegalovirus pneumonia. Chest 1990;98(3): 568-575.
96. Solans EP, Garrity ER Jr, McCabe M, Martinez R, Husain AN. Early diagnosis of cytomegalovirus pneumonitis in lung transplant patients. Arch Pathol Lab Med 1995;119(1):33-35.
97. Hilborne LH, Nieberg RK, Cheng L, Lewin KJ. Direct in situ hybridization for rapid detection of cytomegalovirus in bronchoalveolar lavage. Am J Clin Pathol 1987;87(6):766-769.
98. Metersky ML, Harrell JH 2d, Moser KM. Lack of utility of bronchial brush biopsy in patients infected with the human immunodeficiency virus. Chest 1992;101(3):680-683.
99. Flint A, Beckwith AL, Naylor B. Pneumocystis carinii pneumonia. Cytologic manifestations and rapid diagnosis in routinely prepared Papanicolaou-stained preparations. Am J Med 1986;81(6):1009-1011.
100. Dugan JM, Avitabile AM, Rossman MD, Ernst CS, Atkinson BF. Diagnosis of Pneumocystis carinii pneumonia by cytologic evaluation of Papanicolaou-stained bronchial specimens. Diagn Cytopathol 1988;4(2):106-112.
101. Kim H-K, Hughes WT. Comparison of methods for identification of Pneumocystis carinii in pulmonary aspirates. Am J Clin Pathol 1973;60(4):462-466.
102. Leibovitz E, Pollack H, Rigaud M, Kaul A, Persaud D, Gallo L, et al. Polymerase chain reaction is more sensitive than standard cytologic stains in detecting Pneumocystis carinii in bronchoalveolar lavages from human immunodeficiency virus type 1-infected infants and children with pneumonia. Pediatr Infect Dis J 1995; 14(8):714-716.
103. Chechani V, Allam AA, Haseeb MA. Kamholz SL. Pneumocystis carinii pneumonia in patients with AIDS: evaluation of lavage and staining techniques in diagnosis. J Acquir Immune Defic Syndr 1991; 4(3):250-253.
104. Bartlett JG, Finegold SM. Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates. Am Rev Respir Dis 1978;117(6):1019-1027.
105. Baselski V. Microbiologic diagnosis of ventilator-associated pneumonia. Infect Dis Clin North Am 1993;7(2):331-357.
106. Scheld WM, Mandell GL. Nosocomial pneumonia: pathogenesis and recent advances in diagnosis and therapy. Rev Infect Dis 1991;13(Suppl 9):S743-S751.
107. Marquette CH, Copin MC, Wallet F, Neviere R, Saulnier F, Mathieu D, et al. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med 1995;151(6): 1878-1888.
108. Sternberg RI, Baughman RP, Dohn MN, First MR. Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal transplant recipients. Am J Med 1993;95(4):358-364.
109. Fossieck BE Jr, Parker RH, Cohen MH, Kane RC. Fiberoptic bronchoscopy and culture of bacteria from the lower respiratory tract. Chest 1977;72(1):5-9.
110. Roger-Moreau I, de Barbeyrac B, Ducoudre M, Hubert G, Gbikpi-Benissan G, Cardinaud JP, Bebear C. Evaluation of bronchoalveolar lavage for the diagnosis of bacterial pneumonia in ventilated patients. Ann Biol Clin Paris 1992;50(8):587-591.
111. Papazian L, Thomas P, Garbe L, Guignon I, Thirion X, Charrel J, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 1995;152(6, Part 1):1982-1991.
112. Timsit JF, Misset B, Goldstein FW, Vaury P, Carlet J. Reappraisal of distal diagnostic testing in the diagnosis of ICU-acquired pneumonia. Chest 1995;108(6):1632-1639.
113. Torres A, el Ebiary M, Padro L, Gonzalez J, de la Bellacasa JP, Ramirez J, et al. Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med 1994; 149(2, Part 1):324-331.
114. Chastre J, Fagon JY, Lamer C. Procedures for the diagnosis of pneumonia in ICU patients. Intensive Care Med 1992;18(Suppl 1);S10-17.
115. Jimenez P, Saldias F, Meneses M, Silva ME, Wilson MG, Otth L. Diagnostic fiberoptic bronchoscopy in patients with community-acquired pneumonia. Comparison between bronchoalveolar lavage and telescoping plugged catheter cultures. Chest 1993;103(4): 1023-1027.
116. Sole-Violan J, Rodriguez de Castro F, Caminero-Luna J, Bordes-Benitez A, Manzano-Alonso JL. Comparative efficacy of bronchoalveolar lavage and telescoping plugged catheter in the diagnosis of pneumonia in mechanically ventilated patients. Chest 1993;103(2):386-390.
117. Speich R, Wust J, Hess T, Kayser FH, Russi EW. Prospective evaluation of a semiquantitative dip slide method compared with quantitative bacterial cultures of BAL fluid. Chest 1996;109(6):1423-1429.
118. Riedler J, Grigg J, Robertson CF. Role of bronchoalveolar lavage in children with lung disease. Eur Respir J 1995;8(10): 1725-1730.
119. Yagoda MR, Stavola J, Ward R, Steinberg C, Jones J. Role of bronchoalveolar lavage in hospitalized pediatric patients. Ann Otol Rhinol Laryngol 1996;105(11):863-867.
120. Sorensen J, Forsberg P, Hakanson E, Maller R, Sederholm C, Soren L, Carlsson C. A new diagnostic approach to the patient with severe pneumonia. Scand J Infect Dis 1989;21(1):33-41.
121. Torres A, Martos A, Puig de la Bellacasa J, Ferrer M, el Ebiary M, Gonzalez J, Gene A, Rodriguez-Roisin R. Specificity of endotracheal aspiration, protected specimen brush, and bronchoalveolar lavage in mechanically ventilated patients. Am Rev Respir Dis 1993;147(4): 952-957.
122. Rouby JJ, Rośsignon MD, Nicolas MH, Martin de Lassale E, Cristin S. A prospective study of protected bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. Anesthesiology 1989;71(5): 679-685.
123. Meduri GU, Beals DH, Maijub AG, Baselski V. Protected bronchoalveolar lavage. A new bronchoscopic technique to retrieve uncontaminated distal airway secretions. Am Rev Respir Dis 1991;143(4, Part 1):855-864.
124. Humphreys H, Winter R, Baker M, Smith C. Comparison of bronchoalveolar lavage and catheter lavage to confirm ventilator-associated lower respiratory tract infection. J Med Microbiol 1996;45(3): 226-231.
125. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991;143(5, Part 1):1121-1129.
126. Ricou B, Grandin S, Nicod L, Thorens JB, Suter PM. Adult and paediatric size bronchoscopes for bronchoalveolar lavage in mechanically ventilated patients: yield and side effects. Thorax 1995;50(3): 290-293.
127. Kim TC, Blackman RS, Heatwole KM, Kim T, Rochester DF. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment. Am Rev Respir Dis 1984;129(2): 264-268.
128. Charoenratanakul S, Dejsomritrutai W, Chaiprasert A. Diagnostic role of fiberoptic bronchoscopy in suspected smear negative pulmonary tuberculosis. Respir Med 1995;89(9):621-623.
129. Ip M, Chau PY, So SY, Lam WK. The value of routine bronchial aspirate culture at fibreoptic bronchoscopy for the diagnosis of tuberculosis. Tubercle 1989;70(4):281-285.
130. Levy H, Feldman C, Kallenbach JM. The diagnostic yield of prebronchoscopy sputa and bronchial washings in patients with biopsy-proven pulmonary tuberculosis. S Afr Med J 1989;75(11):527-528.
131. Mohan A, Pande JN, Sharma SK, Rattan A, Guleria R, Khilnani GC. Bronchoalveolar lavage in pulmonary tuberculosis: a decision analysis approach. QJM 1995;88(4):269-276.
132. Schmidt RM, Rosenkranz HS. Antimicrobial activity of local anesthetics: lidocaine and procaine. J Infect Dis 1970;121 (6):597-607.
133. Meduri GU, Baselski V. The role of bronchoalveolar lavage in diagnosing nonopportunistic bacterial pneumonia. Chest 1991;100(1): 179-190.
134. Sharma SK, Pande JN, Verma K. Bronchoalveolar lavage (BAL) in miliary tuberculosis. Tubercle 1988;69(3):175-178.
135. Chan CH, Chan RC, Arnold M, Cheung H, Cheung SW, Cheng AF. Bronchoscopy and tuberculostearic acid assay in the diagnosis of sputum smear-negative pulmonary tuberculosis: a prospective study with the addition of transbronchial biopsy. Q J Med 1992;82(297):15-23.
136. Osumi M, Toyoda T, Kawashiro T, Aoyagi T. Detection of Mycobacterium tuberculosis in clinical specimens other than sputum by a specific DNA probe with amplification of the ribosomal RNA. Kansenshogaku Zasshi 1995;69(12):1376-1382.
137. Pushpakom R, Boronkittis S, Ong-ajyuth S, Vanittankom N. Adenosine deaminase activity in bronchoalveolar lavage fluids: Test for diagnosing of pulmonary tuberculosis. Thia J Tuberc Chest Dis 1988;9: 63-79.
138. Albera C, Mabritto I, Ghio P, Solidoro P, Marchetti L, Pozzi E. Adenosine deaminase activity and fibronectin levels in bronchoalveolar lavage fluid in sarcoidosis and tuberculosis. Sarcoidosis 1993; 10(1):18-25.
139. Hoheisel GB, Tabak L, Teschler H, Erkan F, Kroegel C, Costabel U. Bronchoalveolar lavage cytology and immunocytology in pulmonary tuberculosis. Am J Respir Crit Care Med 1994; 149(2, Part 1):460-463.
140. Yu CT, Wang CH, Huang TJ, Lin HC, Kuo HP. Relation of bronchoalveolar lavage T lymphocyte subpopulations to rate of regression of active pulmonary tuberculosis. Thorax 1995;50(8):869-874.
141. Law K, Weiden M, Harkin T, Tchou-Wong K, Chi C, Rom WN. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med 1996;153 (2):799-804.
142. Hoheisel G, Zheng L, Teschler H, Striz I, Costabel U. Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis. Chest 1995; 108(6):1614-1616.
143. Rimmer J, Gibson P, Bryant DH. Extension of pulmonary tuberculosis after fibreoptic bronchoscopy. Tubercle 1988;69(1):57-61.
144. Reeves DS, Brown NM. Mycobacterial contamination of fiberoptic bronchoscopes. J Hosp Infect 1995;30(Suppl):531-536.
145. Lieberman D, Porath A, Schlaeffer F, Lieberman D, Boldur I. Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients. Chest 1996;109(5):1243-1249.
146. Tsai TF, Fraser DW. The diagnosis of Legionnaires' disease. Ann Intern Med 1978;89(3):413-414.
147. Kohorst WR, Schonfeld SA, Macklin JE, Whitcomb ME. Rapid diagnosis of Legionnaires' disease by bronchoalveolar lavage. Chest 1983; 84(2):186-190.
148. Winn WC Jr, Pasculle AW. Laboratory diagnosis of infections caused by Legionella species. Clin Lab Med 1982;2(2):343-369.
149. Crawford SW, Bowden RA, Hackman RC, Gleaves CA, Meyers JD, Clark JG. Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture. Ann Intern Med 1988;108(2):180-185.
150. Masih A, Rennard SI, Binkley LI, Thomson AB, Linder J. Detection of cytomegalovirus in bronchoalveolar lavage specimens by cytology, tissue culture, fluorescent monoclonal antibodies and in situ hybridization. Acta Cytologica 1987;31(5):648.
151. Mandanas RA, Saez RA, Selby GB, Confer DL. Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy. Am J Hematol 1996;51(2):104-111.
152. Hayner CE, Baughman RP, Linnemann CC Jr, Dohn MN. The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV. Chest 1995;107(3):735-740.
153. Cathomas G, Morris P, Pekle K, Cunningham I, Emanuel D. Rapid diagnosis of cytomegalovirus pneumonia in marrow transplant recipients by bronchoalveolar lavage using the polymerase chain reaction, virus culture, and the direct immunostaining of alveolar cells. Blood 1993;81(7):1909-1914.
154. Delvenne P, Arrese JE, Thiry A, Borlee-Hermans G, Pierard GE, Boniver J. Detection of cytomegalovirus, Pneumocystis carinii, and Aspergillus species in bronchoalveolar lavage fluid. A comparison of techniques. Am J Clin Pathol 1993;100(4):414-418.
155. Smith B, Verghese A, Guiterrez C, Dralle W, Berk SL. Pulmonary strongyloidiasis. Diagnosis by sputum gram stain. Am J Med 1985;79 (5):663-666.
156. Venizelos P, Lopata M, Bardawil WA, Sharp JT. Respiratory failure due to Strongyloides stercoralis in a patient with a renal transplant. Chest 1980;78:104-106.
157. Froes HP. Identification of Nematoda larva in exudate of serohemorrhagic pleural effusion. J Trop Med 1930;33:18-19.
158. Williams J, Nunley D, Dralle W, Berk SL, Verghese A. Diagnosis of pulmonary strongyloidiasis by bronchoalveolar lavage. Chest 1988; 94(3):643-644.
159. Remadi S, Dumais J, Wafa K, MacGee W. Pulmonary microsporidiosis in a patient with the acquired immunodeficiency syndrome. A case report. Acta Cytol 1995;39(6):1112-1116.
160. Fisher BD, Armstrong D, Yu B, Gold JW. Invasive aspergillosis. Progress in early diagnosis and treatment. Am J Med 1981;71(4): 571-577.
161. Hahn HH, Beaty HN. Transtracheal aspiration in the evaluation of patients with pneumonia. Ann Intern Med 1970;72(2): 183-187.
162. Pennington JE. Aspergillus pneumonia in hematologic malignancy. Improvements in diagnosis and therapy. Arch Intern Med 1977;137(6): 769-771.
163. von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995;62(6):341-347.
164. Kahn FW, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 1986;86(4):518-523.
165. Cazzadori A, Di Perri G, Todeschini G, Luzzati R, Boschiero L, Perona G, Concia E. Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients. Chest 1995;107(1): 101-106.
166. Ellis ME, Spence D, Bouchama A, Antonius J, Bazarbashi M, Khougeer F, De Vol EB. Open lung biopsy provides a higher and more specific diagnostic yield compared to bronchoalveolar lavage in immunocompromised patients. Fungal Study Group. Scand J Infect Dis 1995;27(2):157-162.
167. Hopkins JM, Young JA, Turney JH, Michael J, Adva D. Rapid diagnosis of obscure pneumonia in immunosuppressed renal patients by cytology or alveolar lavage fluid. Lancet 1983;2(8345):299-301.
168. Gallardo J, Sasal M, Ferreres JC. Diagnosis of histoplasmosis in bronchoalveolar lavage fluid [letter] Acta Cytol 1995;39(3): 595-596.
169. von Eiff M, Zuhlsdorf M, Roos N, Hesse M, Schulten R, van de Loo J. Pulmonary fungal infections in patients with hematological malignancies - diagnostic approaches. Ann Hematol 1995;70(3):135-141.
170. Lewin SR, Hoy J, Crowe SM, McDonald CF. The role of bronchoscopy in the diagnosis and treatment of pulmonary disease in HIV-infected patients. Aust N Z J Med 1995;25(2):133-139.
171. Pinkston P, Pelletier N, Arena C, Schock J, Garland R, Rose RM. Quantitative culture of HIV-1 from bronchoalveolar lavage cells. Am J Respir Crit Care Med 1995;152(1):254-259.
172. Taylor IK, Coker RJ, Clarke J, Moss FM, Nieman R, Evans DJ, et al. Pulmonary complications of HIV disease: 10 year retrospective evaluation of yields from bronchoalveolar lavage, 1983-93. Thorax 1995;50(12):1240-1245.
173. von Eiff M, Schlingheider O, Schulze F, Zuhlsdorf M, van de Loo J. Differential cell count and lymphocyte subsets in bronchoalveolar lavage during pneumonia with and without peripheral neutropema. Lung 1995;173(1):25-33.
174. Hopewell PC. Pneumocystis carinii pneumonia: diagnosis. J Infect Dis 1988;157(6):1115-1119.
175. DeVita VT, Emmer M, Levine A, Jacobs B, Berard C. Pneumocystis carinii pneumonia: Successful diagnosis and treatment of two patients with associated malignant processes. N Engl J Med 1969;280(6): 287-291.
176. Johnson HD, Johnson WW. Pneumocystic carinii pneumonia in children with cancer: Diagnosis and treatment. JAMA 1970;214(6): 1067-1073.
177. Repsher LH, Schroter G, Hammond WS. Diagnosis of Pneumocystis carinii pneumonitis by means of endobronchial brush biopsy. N Engl J Med 1972;287(7):340-341.
178. Martin WR, Albertson TE, Siegel B. Tracheal catheters in patients with acquired immunodeficiency syndrome for the diagnosis of Pneumocystis carinii pneumonia. Chest 1990;98(1):29-32.
179. Kirsch CM, Azzi RL, Yenokida GG, Jensen WA. Analysis of induced sputum in the diagnosis of Pneumocystis carinii pneumonia. Am J Med Sci 1990;299(6):386-391.
180. Norman L, Kagan IG. Some observations on the serology of Pneumocystis carinii infections in the United States. Infect Immun 1973; 8(3):317-321.
181. del Rio C, Guarner J, Honig EG, Slade BA. Sputum examination in the diagnosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1988;112(12): 1229-1232.
182. Leigh TR, Parsons P, Hume C, Husain OA, Gazzard B, Collins JV. Sputum induction for diagnosis of Pneumocystis carinii pneumonia. Lancet 1989;2(8656):205-206.
183. Chouaid C, Housset B, Poirot JL, Roux P, Lebeau B. Cost effectiveness of the induced sputum technique for the diagnosis of Pneumocystis carinii pneumonia (PCP) in HIV-infected patients. Eur Respir J 1993;6(2):248-252.
184. Drew WL, Finley TN, Mintz L, Klein HZ. Diagnosis of Pneumocystis carinii pneumonia by bronchopulmonary lavage. JAMA 1974; 230(5):713-715.
185. Golden JA, Hollander H, Stulbarg MS, Gamsu G. Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia. A prospective study among patients with acquired immunodeficiency syndrome. Chest 1986;90(1):18-22.
186. Orenstein M, Webber CA, Heurich AE. Cytologic diagnosis of Pneumocystis carinii infection by bronchoalveolar lavage in acquired immune deficiency syndrome. Acta Cytol 1985;29(5):727-731.
187. Tiley SM, Marriott DJ, Harkness JL. An evaluation of four methods for the detection of Pneumocystis carinii in clinical specimens. Pathology 1994;26(3):325-328.
188. Armbruster C, Pokieser L, Hassl A. Diagnosis of Pneumocystis carinii pneumonia by bronchoalveolar lavage in AIDS patients. Comparison of Diff-Quik, fungifluor stain, direct immunofluorescence test and polymerase chain reaction. Acta Cytol 1995;39(6) :1089-1093.
189. Elvin KM, Bjorkman A, Linder E, Heurlin N, Hjerpe A. Pneumocystis carinii pneumonia: detection of parasites in sputum and bronchoalveolar lavage fluid by monoclonal antibodies. BMJ 1988;297 (6645):381-384.
190. Wazir JF, Macrorie SG, Coleman DV. Evaluation of the sensitivity, specificity, and predictive value of monoclonal antibody 3F6 for the detection of Pneumocystis carinii pneumonia in bronchoalveolar lavage specimens and induced sputum. Cytopathology 1994;5(2): 82-89.
191. Leibovitz E, Pollack H, Moore T, Papellas J, Gallo L, Krasinski K, Borkowsky W. Comparison of PCR and standard cytological staining for detection of Pneumocystis carinii from respiratory specimens from patients with or at high risk for infection by human immunodeficiency virus. J Clin Microbiol 1995;33(11):3004-3007.
192. Torrington KG, Finelli MR. Small volume bronchoalveolar lavage used in diagnosing Pneumocystis carinii pneumonia in HIV-infected patients. Chest 1995;107(4):1013-1017.
193. Tamburrini E, Mencarini P, De Luca A, Maiuro G, Ventura G, Antinori A, et al. Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens. J Med Microbiol 1993;38(6):449-453.
194. Sternberg RI, Whitsett JA, Hull WM, Baughman RP. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid. J Lab Clin Med 1995;125(4):462-469.
195. Gadea I, Cuenca M, Benito N, Pereda JM, Soriano F. Bronchoalveolar lavage for the diagnosis of disseminated toxoplasmosis in AIDS patients. Diagn Microbiol Infect Dis 1995;22(4):339-341.
196. Contini C, Romani R, Magno S, Delia S. Diagnosis of Toxoplasma gondii infection in AIDS patients by a tissue-culture technique. Eur J Clin Microbiol Infect Dis 1995;14(5):434-440.
197. MacMahon H, Courtney JV, Little AG. Diagnostic methods in lung cancer. Semin Oncol 1983;10(1):20-33.
198. Semenzato G, Poletti V. Bronchoalveolar lavage in lung cancer. Respiration 1992;59(Suppl 1):44-46.
199. Rennard SI. Bronchoalveolar lavage in the assessment of primary and metastatic lung cancer. Respiration 1992;59(Suppl 1):41-43.
200. Wallace RH, Kolbe J. Fibreoptic bronchoscopy and bronchoalveolar lavage in the investigation of the immunocompromised lung. N Z Med J 1992;105(935):215-217.
201. Abramson MJ, Stone CA, Holmes PW, Tai EH. The role of bronchoalveolar lavage in the diagnosis of suspected opportunistic pneumonia. Aust N Z J Med 1987;17(4):407-412.
202. Rennard SI. Bronchoalveolar lavage in the diagnosis of cancer. Lung 1990;168(Suppl):1035-1040.
203. Semenzato G, Spatafora M, Feruglio C, Pace E, Di Pietro V. Bronchoalveolar lavage and the immunology of lung cancer. Lung 1990; 16:(Suppl):1041-1049.
204. Noppen M, Slabbynck H, De Waele M, Lacor P, Monsieur I, Vincken W. Immunogold-silver staining of cells recovered by bronchoalveolar lavage. A report of three cases demonstrating its value in the diagnosis of pulmonary involvement in hematologic malignancies. Acta Cytol 1995;39(6):1141-1147.
205. Linder J, Radio SJ, Robbins RA, Ghafouri M, Rennard SI. Bronchoalveolar lavage in the cytologic diagnosis of carcinoma of the lung. Acta Cytol 1987;31(6):796-801.
206. Biyoudi-Vouenze R, Tazi A, Hance AJ, Chastre J, Basset F, Soler P. Abnormal epithelial cells recovered by bronchoalveolar lavage: are they malignant? Am Rev Respir Dis 1990;142(3):686-690.
207. Linder J, Rennard S. Bronchoalveolar lavage. ASCP Press 1988.
208. Sestini P, Rottoli L, Gotti G, Miracco C, Luzi P. Bronchoalveolar lavage diagnosis of bronchiole-alveolar carcinoma. Eur J Respir Dis 1985;66(1):55-58.
209. de Gracia J, Bravo C, Miravitlles M, Tallada N, Orriols R, Bellmunt J, et al. Diagnostic value of bronchoalveolar lavage in peripheral lung cancer. Am Rev Respir Dis 1993;147(3):649-652.
210. Pirozynski M. Bronchoalveolar lavage in the diagnosis of peripheral, primary lung cancer. Chest 1992;102(2):372-374.
211. Rossi GA, Balbi B, Risso M, Repetto M, Ravazzoni C. Acute myelomonocytic leukemia. Demonstration of pulmonary involvement by bronchoalveolar lavage. Chest 1985;87(2):259-260.
212. Menashe P, Stenson W, Reynoso G, Keane M, Nair KG, Nelson G. Bronchoalveolar lavage plasmacytosis in patient with a plasma cell dyscrasia. Chest 1989;95(1):226-227.
213. Miller KS, Sahn SA. Mycosis fungoides presenting as ARDS and diagnosed by bronchoalveolar lavage. Radiographic and pathologic pulmonary manifestations. Chest 1986;89(2):312-314.
214. Kobayashi H, Ii K, Hizawa K, Maeda T. Two cases of pulmonary Waldenstrom's macroglobulinemia. Chest 1985;88(2):297-299.
215. Gallagher CJ, Knowles GK, Habeshaw JA, Green M, Malpas JS, Lister TA. Early involvement of the bronchi in patients with malignant lymphoma. Br J Cancer 1983;48(6):777-781.
216. Morales FM, Matthews JI. Diagnosis of parenchymal Hodgkin's disease using bronchoalveolar lavage. Chest 1987;91(5):785-787.
217. Oka M, Kawano K, Kanda T, Hara K. Bronchoalveolar lavage in primary pulmonary lymphoma with monoclonal gammopathy. Am Rev Respir Dis 1988;137(4):957-959.
218. Keicho N, Oka T, Takeuchi K, Yamane A, Yazaki Y, Yotsumoto H. Detection of lymphomatous involvement of the lung by bronchoalveolar lavage. Application of immunophenotypic and gene rearrangement analysis. Chest 1994;105(2):458-462.
219. Davis WB, Gadek JE. Detection of pulmonary lymphoma by bronchoalveolar lavage. Chest 1987;91(5):787-790.
220. Pisani RJ, Witzig TE, Li CY, Morris MA, Thibodeau SN. Confirmation of lymphomatous pulmonary involvement by immunophenotypic and gene rearrangement analysis of bronchoalveolar lavage fluid. Mayo Clin Proc 1990;65(5):651-656.
221. Maejima S, Kitano K, Ichikawa S, Kaneko T, Saito H, Kiyosawa K, Furuta S. T-cell non-Hodgkin's lymphoma of the lung. Intern Med 1993;32(5):403-407.
222. Poletti V, Romagna M, Gasponi A, Baruzzi G, Allen KA. Bronchoalveolar lavage in the diagnosis of low-grade, MALT type, B-cell lymphoma in the lung. Monaldi Arch Chest Dis 1995;50(3):191-194.
223. Winer-Muram HT, Rubin SA, Kauffman WM, Jennings SG, Arheart KL, Sandlund JT, Bozeman PM. Childhood lymphoma: diagnostic accuracy of chest radiography for severe pulmonary complications. Clin Radiol 1995;50(12):842-847.
224. Rodriguez de Castro F, Molero T, Julia-Serda G, Caminero J, Cabrera P. DNA analysis of bronchoalveolar lavage in the diagnosis of pulmonary lymphoma. Respiration 1995;62(6):359-360.
225. Verstraeten A, Sault MC, Wallaert B, Lemonnier P, Gosselin B, Tonnel AB. Metastatic prostatic adenocarcinoma-diagnosed by bronchoalveolar lavage and tumour marker determination. Eur Respir J 1991;4(10):1296-1298.
226. Fernandez K, O'Hanlan KA, Rodriguez-Rodriguez L, Marino WD. Respiratory failure due to interstitial lung metastases of ovarian carcinoma reversed by chemotherapy. Chest 1991;99(6):1533-1534.
227. Radio SJ, Rennard SI, Kessinger A, Vaughan WP, Linder J. Breast carcinoma in bronchoalveolar lavage. A cytologic and immunocytochemical study. Arch Pathol Lab Med 1989;113(4):333-336.
228. Mello CJ, Veronikis I, Fraire AE, Aronin N, Irwin RS, Braverman LE. Metastatic papillary thyroid carcinoma to lung diagnosed by bronchoalveolar lavage. J Clin Endocrinol Metab 1996;81(1):406-410.
229. Levy H, Horak DA, Lewis MI. The value of bronchial washings and bronchoalveolar lavage in the diagnosis of lymphangitic carcinomatosis. Chest 1988;94(5):1028-1030.
230. Poletti V, Romagna M, Allen KA, Gasponi A, Spiga L. Bronchoalveolar lavage in the diagnosis of disseminated lung tumors. Acta Cytol 1995;39(3):472-477.
231. Von Eiff M, Koch O, Appelhans N, Roos N, Van de Loo J. Diagnostic significance of the tumor markers CEA, SCC, and NSE in serum and bronchoalveolar lavage (Ger). Pneumologie 1990;44:(Suppl): 462-464.
232. Macchia V, Mariano A, Cavalcanti M, Coppa A, Cecere C, Fraioli G, et al. Tumor markers and lung cancer: correlation between serum and bronchial secretion levels of CEA, TPA, CanAg CA-50, NSE and ferritin. Int J Biol Markers 1987;2(3):151-156.
233. Hirakata Y, Kobayashi J, Sugama Y, Kitamura S. Elevation of tumour markers in serum and bronchoalveolar lavage fluid in pulmonary alveolar proteinosis. Eur Respir J 1995;8(5):686-696.
234. Ohwada A, Takahashi H, Nagaoka I, Iwabuchi K, Mikami O, Kira S. Effect of cigarette smoke on the mRNA and protein expression of carcinoembryonic antigen (CEA), a possible chemoattractant for neutrophils in human bronchoalveolar tissues. Thorax 1995;50(6):651-657.
235. Sanguinetti CM, Riccioni G, Marchesani F, Pela R, Cecarini L. Bronchoalveolar lavage fluid level of carcinoembryonic antigen in the diagnosis of peripheral lung cancer. Monaldi Arch Chest Dis 1995;50(3): 177-182.
236. Hernandez-Hernandez JR, Garcia-Garcia JM, Martinez-Muniz MA, Allende-Monclus MT, Ruibal-Morell A. Clinical utility of hyaluronic values in serum and bronchoalveolar lavage fluid as tumor marker for bronchogenic carcinoma. Int J Biol Markers 1995;10(3):149-155.
237. Mills NE, Fishman CL, Scholes J, Anderson SE, Rom WN, Jacobson DR. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J Natl Cancer Inst 1995;87(14):1056-1060.
238. Pisani RJ, Cortese DA, Homburger HA, Grambsch PM. A prospective pilot study evaluating the effectiveness of secretory IgA measurements in bronchoalveolar lavage to detect non-small cell lung cancer. Chest 1990;97(3):586-589.
239. Lefever A, Funahashi A. Elevated prostaglandin E2 levels in bronchoalveolar lavage fluid of patients with bronchogenic carcinoma. Chest 1990;98(6):1397-1402.
240. Sahn SA, Scoggin C. Fiberoptic bronchoscopy in bronchial asthma. A word of caution. Chest 1976;69(1):39-42.
241. Roisman GL, Lacronique JG, Desmazes-Dufen N, Carre C, Le Cae A, Dusser DJ. Airway responsiveness to bradykinin is related to eosinophilic inflammation in asthma. Am J Respir Crit Care Med 1996;153(1):381-390.
242. Bensein IL, Boushey HA, Cherniack RM. Summery and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatic patients. Chest 1985;88:136-138.
243. Michel FB, Godard P, Bousquet J. Usefulness of bronchoalveolar lavage in asthmatics. The right clinical practice. Int Arch Allergy Appl Immunol 1989;88(1-2):101-107.
244. Yousefi S, Hemmann S, Weber M, Holzer C, Hartung K, Blaser K, Simon HU. IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol 1995;154 (10):5481-5490.
245. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137(1):62-69.
246. Robinson DS, Assoufi B, Durham SR, Kay AB. Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment. Clin Exp Allergy 1995;25(11):1118-1127.
247. Joos GF, Kips JC, Peleman RA, Pauwels RA. Tachykinin antagonists and the airways. Arch Int Pharmacodyn Ther 1995;329(1): 205-219.
248. Heaney LG, Cross LJ, Stanford CF, Ennis M. Substance P induces histamine release from human pulmonary mast cells. Clin Exp Allergy 1995;25(2):179-186.
249. Jarjour NN, Busse WW. Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma. Am J Respir Crit Care Med 1995;152 (5, Part 1):1474-1477.
250. Gurd AR. Fat embolism: an aid to diagnosis. J Bone Joint Surg Br 1970,52(4):732-737.
251. Gossling HR, Donohue TA. The fat embolism syndrome. JAMA 1979;241(25):2740-2742.
252. Lepisto P, Alho A. Diagnostic features of the fat embolism syndrome. Acta Chir Scand 1975;141(4):245-250.
253. Roger N, Xaubet A, Agusti C, Zabala E, Ballester E, Torres A, et al. Role of bronchoalveolar lavage in the diagnosis of fat embolism syndrome. Eur Respir J 1995;8(8):1275-1280.
254. Lambert SB, Frazier-Jessen MR, VanStedum S, Hahn EL, Filkins JP, Garrity ER Jr, Kovacs EJ. Bronchoalveolar lavage fluid endotoxin elevation in human single lung transplant recipients during rejection. Transpl Immunol 1995;3(1):81-85.
255. Wilkes DS, Heidler KM, Niemeier M, Schwenk GR, Mathur PN, Breite WM, et al. Increased bronchoalveolar IgG2/IgG1 ratio is a marker for human lung allograft rejection. J Investig Med 1994;42(4):652-659.
256. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3, Part 1):818-824.
257. Snyder LS, Hertz MI, Harmon KR, Bitterman PB. Failure of lung repair following acute lung injury. Regulation of the fibroproliferative response (Part 1). Chest 1990;98(3):733-738.
258. Hyers TM, Tricomi SM, Dettenmeier PA, Fowler AA. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1991;144(2):268-271.
259. Stricter RM, Lynch JP 3rd, Basha MA, Standiford TJ, Kasahara K, Kunkel SL. Host responses in mediating sepsis and adult respiratory distress syndrome. Semin Respir Infect 1990;5(3):233-247.
260. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995;108(5): 1303-1314.
261. Modig J, Hallgren R. Pathophysiologic significance of lung granulocytes in human adult respiratory distress syndrome induced by septic or traumatic shock. Acta Chir Scand 1987;153(4):267-271.
262. Lee CT, Fein AM, Lippmann M, Holtzman H, Kimbel P, Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. N Engl J Med 1981;304(4): 192-196.
263. Wewers MD, Herzyk DJ, Gadek JE. Alveolar fluid neutrophil elastase activity in the adult respiratory distress syndrome is complexed to alpha-2-macroglobulin. J Clin Invest 1988;82(4):1260-1267.
264. Krsek-Staples JA, Kew RR, Webster RO. Ceruloplasmin and transferrin levels are altered in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1992;145(5):1009-1015.
265. Lykens MG, Davis WB, Pacht ER. Antioxidant activity of bronchoalveolar lavage fluid in the adult respiratory distress syndrome. Am J Physiol 1992;262 (2, Part 1):L169-175.
266. Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985;132(3):485-489.
267. Bell RC, Coalson JJ, Smith JD, Johanson WG Jr. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1983;99(3):293-298.
268. Leeper KV Jr. Diagnosis and treatment of pulmonary infections in adult respiratory distress syndrome. New Horiz 1993;1(4):550-562.
269. Steinberg KP, Mitchell DR, Maunder RJ, Milberg JA, Whitcomb ME, Hudson LD. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1993;148(3): 556-561.
270. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med 1984;310(3):154-166.
271. DePaso WJ, Winterbauer RH. Interstitial lung disease. Dis Mon 1991;37(2):61-133.
272. Lynch JP III, Chavis AD. Chronic interstitial lung disorders. In: Victor L, editor. Clinical pulmonary medicine. Boston: Little Brown; 1992:193-264.
273. Dhillon DP, Haslam PL, Townsend PJ, Primett Z, Collins JV, Turner-Warwick M. Bronchoalveolar lavage in patients with interstitial lung diseases. side effects and factors affecting fluid recovery. Eur J Respir Dis 1986;68(5):342-350.
274. Calvanico NJ, Ambegaonkar SP, Schlueter DP, Fink JN. Immunoglobulin level in bronchoalveolar lavage fluid from pigeon breeds. J Lab Clin Med 1980;96(1):129-140.
275. Carrington CB. Structure and function in sarcoidosis. Ann NY Acad Sci 1976;278:265-283.
276. Schlueter DP. Response of the lung to inhaled antigens. Am J Med 1974;57(3):476-492.
277. Carrington CB, Gaensler EA, Coutu RE, FitzGerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonitis. N Engl J Med 1978;298(15):801-809.
278. Phillips BA, Cooper KR, Fratkin MJ. Effect of bronchoscopy on localization of gallium-67 citrate. Am Rev Respir Dis 1983;127(3):342-343.
279. Merrill WW, Reynolds HY. Bronchial lavage in inflammatory lung disease. Clin Chest Med 1983;4(1):71-84.
280. Xaubet A, Moises JA, Agusti C, Martos JA, Picado C. Identification of mast cells in bronchoalveolar lavage fluid. Comparison between different fixation and staining methods. Allergy 1991;46(2):227.
281. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY. Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 1976;85(6):769-788.
282. Cullen MR, Merrill WW. Association between neutrophil concentration in bronchoalveolar lavage fluid and recent losses in diffusing capacity in men formerly exposed to asbestos. Chest 1992;102(3): 682-687.
283. Izumi T, Kitaićhi M, Nishimura K, Nagai S. Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis. Chest 1992;102(3):715-719.
284. Popp W, Braun O, Ritschka L, Scherak O, Kolarz G, Rauscher H, et al. Chest x-ray in collagen vascular diseases. A comparison of chest x-ray with bronchoalveolar lavage and transbronchial forceps biopsy. Respiration 1994;61(3):138-143.
285. Wells AU, Hansell DM, Rubens MB, Cullinan P, Haslam PL, Black CM, DuBois RM. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance. Am J Respir Crit Care Med 1994;150(2):462-468.
286. Akoun GM, Cadranel JL, Rosenow EC 3d, Milleron BJ. Bronchoalveolar lavage cell data in drug-induced pneumonitis. Allerg Immunol Paris 1991;23(6):245-252.
287. Khardori R, Eagleton LE, Soler NG, McConnachie PR. Lymphocytic interstitial pneumonitis in autoimmune thyroid disease. Am J Med 1991;90(5):649-652.
288. Roberts CM, Foulcher E, Zaunders JJ, Bryant DH, Freund J, Cairns D, et al. Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction. Ann Intern Med 1993;118(9):696-700.
289. Dalavanga YA, Constantopoulos SH, Galanopoulou V, Zerva L, Moutsopoulos HM. Alveolitis correlates with clinical pulmonary involvement in primary Sjogren's syndrome. Chest 1991;99(6):1394-1397.
290. Schlick W. Current issues in the assessment of interstitial lung disease. Monaldi Arch Chest Dis 1993;48(3):237-244.
291. Ross N, Diederich S, von Eiff M, Vestring T, Peters PE. Computed tomography in noninfectious interstitial lung diseases. Radiologe 1993;100:380-383.
292. Ramsay SC, Yeates MG, Burke WM, Bryant DH, Morgan GW, Breit SN. Quantitative pulmonary gallium scanning in interstitial lung disease. Eur J Nucl Med 1992;19(2):80-85.
293. Raghu G. Interstitial lung disease: a diagnostic approach. Are CT scan and lung biopsy indicated in every patient? Am J Respir Crit Care Med 1995;151(3, Part 1):909-914.
294. Drent M, van Nierop MA, Gerritsen FA, Wouters EF, Mulder PG. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 1996;153 (2):736-741.
295. Weinberger SE, Kelman JA, Elson NA, Young RC Jr, Reynolds HY, Fulmer JD, Crystal RC. Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med 1978;89(4):459-466.
296. Wurtemberger G, Dinkel E, Costabel U, Matthys H. The value of bronchoalveolar lavage in the diagnosis of interstitial lung diseases. Radiologe 1990;30:557-563.
297. Cole P, Turton C, Lanyon H, Collins J. Bronchoalveolar lavage for the preparation of free lung cells: technique and complications. Br J Dis Chest 1980;74(3):273-278.
298. Nugent KM, Peterson MW, Jolles H, Monick MM, Hunninghake GW. Correlation of chest roentgenograms with pulmonary function and bronchoalveolar lavage in interstitial lung disease. Chest 1989;96(6): 1224-1227.
299. Yoshida K, Shijubo N, Koba H, Mori Y, Satoh M, Morikawa T, Abe S. Chronic eosinophilic pneumonia progressing to lung fibrosis. Eur Respir J 1994;7(8):1541-1544.
300. Mitchell DN, Scadding JD. Sarcoidosis. Am Rev Respir Dis 1974; 110:774-802.
301. Martin WJ II, Williams DE, Dines DE, Sanderson DR. Interstitial lung disease. Assessment by bronchoalveolar lavage. Mayo Clin Proc 1983;58(11):751-757.
302. Drent M, Mulder PG, Wagenaar SS, Hoogsteden HC, va Velzen Blad H, van den Bosch JM. Differences in BAL fluid variables in interstitial lung diseases evaluated by discriminant analysis. Eur Respir J 1993;6(6):803-810.
303. Hallgren R, Bjermer L, Lundgren R, Venge P. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis 1989;139(2):373-377.
304. Schwartz DA, Helmers RA, Dayton CS, Merchant RK, Hunninghake GW. Determinants of bronchoalveolar lavage cellularity in idiopathic pulmonary fibrosis. J Appl Physiol 1991;71(5):1688-1693.
305. Winterbauer RH, Lammert J, Selland M, Wu R, Corley D, Springmeyer SC. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 1993;104(2):352-361.
306. Shindoh Y, Shimura S, Tomioka M, Aikawa T, Sasaki H, Takishima T. Cellular analysis in bronchoalveolar lavage fluids in infiltrative and fibrotic stages of idiopathic pulmonary fibrosis. Tohoku J Exp Med 1986;149(1):47-60.
307. Lawrence EC, Martin RR, Blaese RM, Teague RB, Awe RJ, Wilson RK, et al. Increased bronchoalveolar IgG-secreting cells in interstitial lung diseases. N Engl J Med 1980;302(21):1186-1188.
308. Specks U, Martin WJ 2d, Rohrbach MS. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases. Am Rev Respir Dis 1990;141(1):117-123.
309. Allen RK, Pierce RJ, Barter CE. Angiotensin-converting enzyme in bronchoalveolar lavage fluid in sarcoidosis. Sarcoidosis 1992;9(1):54-59.
310. Baum BJ, McDonald JA, Crystal RG. Metabolic fate of the major cell surface protein of normal human fibroblasts. Biochem Biophys Res Commun 1977;79(1):8-15.
311. Yamada KM, Olden K. Fibronectins-adhesive glycoproteins of cell surface and blood. Nature 1978;275(5677):179-184.
312. Menendez R, Marco V, Rubio V, Sole A. Quantification of fibronectin in bronchoalveolar lavage fluid and in lung parenchyma: differences between smokers and non-smokers. Respiration 1995;62(6):312-316.
313. Rennard SI, Crystal RG. Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. J Clin Invest 1982;69(1):113-122.
314. Pohl WR, Conlan MG, Thompson AB, Ertl RF, Romberger DJ, Mosher DF, Rennard SI. Vitronectin in bronchoalveolar lavage fluid is increased in patients with interstitial lung disease. Am Rev Respir Dis 1991;143(6):1369-1375.
315. Alam R, Welter J, Forsythe P, Bousquert J, Rankin J, Boyars M, et al. Histamine release inhibitory factors (HRIF) and histamine releasing factor (HRF) in bronchoalveolar lavage fluids J Allergy Clin Immunol 1989;83 (Suppl):236S.
316. Broide DH, Smith CM, Wasserman SI. Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid. J Immunol 1990;145(6):1838-1844.
317. Walls AF, Bennett AR, Godfrey RC, Holgate ST, Church MK. Mast cell tryptase and histamine concentrations in bronchoalveolar lavage fluid from patients with interstitial lung disease. Clin Sci Colch 1991;81 (2):183-188.
318. Casale TB, Trapp S, Zehr B, Hunninghake GW. Bronchoalveolar lavage fluid histamine levels in interstitial lung diseases. Am Rev Respir Dis 1988;138(6):1604-1608.
319. Pesci A, Bertorelli G, Gabrielli M. Olivieri D. Mast cells in fibrotic lung disorders. Chest 1993;103(4):989-996.
320. Hunninghake GW, Kalica AR. Approaches to the treatment of pulmonary fibrosis. Am J Respir Crit Care Med 1995;151(3, Part 1): 915-918.
321. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980;35(3):171-180.
322. Stack BH, Choo-Kang YF, Heard BE. The prognosis of cryptogenic fibrosing alveolitis. Thorax 1972;27(5):535-542.
323. Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986;133(1):97-103.
324. Hunninghake GW, Gadek JE, Lawley TJ, Crystal RG. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 1981;68(1):259-269.
325. Gadek JE, Kelman JA, Fells G, Weinberger SE, Horwitz AL, Reynolds HY, et al. Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis. N Engl J Med 1979;301(14):737-742.
326. Crystal RG, Fulmer JD, Baum BJ, Bernardo J, Bradley KH, Bruel SD, et al. Cells, collagen and idiopathic pulmonary fibrosis. Lung 1978;155(3):199-224.
327. Haslam PL, Turton CW, Lukoszek A, Salsbury AJ, Dewar A, Collins JV, Turner-Warwick M. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their telation to therapy. Thorax 1980;35(5):328-339.
328. Boomars KA, Wagenaar SS, Mulder PG, van Velzen Blad H, van den Bosch JM. Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis. Thorax 1995;50 (10):1087-1092.
329. Line BR, Fulmer JD, Reynolds HY, Roberts WC, Jones AE, Harris EK, Crystal RG. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: Correlation and physiologic and morphologic features and bronchoalveolar lavage. Am Rev Respir Dis 1978; 118(2):355-365.
330. Turner-Warwick M. Staging and therapy of cryptogenic fibrosing alveolitis. Chest 1986;89 (3, Suppl):148S-150S.
331. Rudd RM, Haslam PL, Turner-Warwick M. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 1981;124(1):1-8.
332. Turner-Warwick M, Haslam PL. The value of serial bronchoalveolar lavage in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1987; 135:26-34.
333. Gelb AF, Dreisen RB, Epstein JD, Silverthorne JD, Bickel Y, Fields M, et al. Immune complexes, gallium lung scans, and bronchoalveolar lavages in idiopathic interstitial pneumonitis-fibrosis. Chest 1983;84(2): 148-153.
334. Maier K, Leuschel L, Costabel U. Increased levels of oxidized methionine residues in bronchoalveolar lavage fluid proteins from patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991;143 (2):271-274.
335. Daniele RP, Henson PM, Fantone JC, Ward PA, Dreisin RB. Immune complex injury of the lung. Symposium held at the 74th annual meeting of the American Thoracic Society, Las Vegas, Nevada, May 1979. Am Rev Respir Dis 1981;124(6):738-755.
336. Haslam PL, Thompson B, Mohammed I, Townsend PJ, Hodson ME, Holborow FJ, Turner-Warwick M. Circulating immune complexes in patients with cryptogenic alveolitis. Clin Exp Immunol 1979;37 (3):381-390.
337. Dreisin RB, Schwarz MI, Theofilopoulos AN, Stanford RE. Circulating immune complexes in the idiopathic interstitial pneumonia. N Engl J Med 1978;298(7):353-357.
338. Turner-Warwick M, Haslam PL, Lukoszek A, Townsend P, Allan F, Du Bois RM, et al. Cells, enzymes and interstitial lung disease. The Philip Ellman Lecture. J R Coll Physicians Lond 1981;15(1):5-16.
339. Milburn HJ, Grundy JE, duBois RM, Prentice HG, Griffiths PD. Humoral immune responses within the lung of bone marrow transplant recipients studied by bronchoalveolar lavage. Clin Exp Immunol 1988;72(2):309-314.
340. McCombs RP. Diseases due to immunologic reactions in the lungs. N Engl J Med 1972;286(22 and 23):1186-1194 and 1245-1252.
341. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 1982;70(3):673-683.
342. McCormack FX, King TE Jr, Voelker DR, Robinson PC, Mason RJ. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis 1991; 144(1):160-166.
343. Lesur OJ, Mancini NM, Humbert JC, Chabot F, Polu JM. Interleukin-6, interferon-gamma, and phospholipid levels in the alveolar lining fluid of human lungs. Profiles in coal worker's pneumoconiosis and idiopathic pulmonary fibrosis. Chest 1994;106(2):407-413.
344. Robinson PC, Watters LC, King TE, Mason RJ. Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids. Am Rev Respir Dis 1988;137(8):585-591.
345. Groopman JE, Golde DW. The histiocytic disorders: a pathophysiologic analysis. Ann Intern Med 1981;94(1):95-107.
346. Corrin B, Busset F. A review of histiocytosis X with particular reference to eosinophilic granuloma of the lung. Invest Cell Pathol 1979; 2(3):137-146.
347. Gracey DR, Divertie MB, Brown AL Jr. Primary pulmonary histiocytosis x: electron microscopic study in eight cases. Chest 1971;59 (1):5-9.
348. Nezelof C, Basset F, Rousseau MF. Histiocytosis X histogenetic argument for a Langerhans cell origin. Biomedicine 1973; 18(5):365-371.
349. Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine-Baltimore 1981;60(6):385-396.
350. Lacronique J, Roth C, Battesti JP, Basset F, Chretien J. Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases. Thorax 1982;37(2):104-109.
351. Chollet S, Soler P, Dournovo P, Richard MS, Ferrans VJ, Basset F. Diagnosis of pulmonary histiocytosis X by immunodetection of Langerhans cells in bronchoalveolar fluid lavage. Am J Pathol 1984;115(2): 225-232.
352. Uebelhoer M, Bewig B, Sternberg K, Rabe K, Nowak D, Magnussen H, Barth J. Alveolar macrophages from bronchoalveolar lavage of patients with pulmonary histiocytosis X: determination of phenotypic and functional changes. Lung 1995;173(3):187-195.
353. Auerswald U, Barth J, Magnussen H. Value of CD-1-positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Lung 1991;169(6):305-309.
354. Murphy GF, Bhan AK, Sato S, Mihm MC Jr, Harrist TJ. A new immunologic marker for human Langerhans cells [letter]. N Engl J Med 1981;304(13):791-792.
355. King TE Jr, Schwarz MI, Dreisin RE, Pratt DS, Theofilopoulos AN. Circulating immune complexes in pulmonary eosinophilic granuloma. Ann Intern Med 1979;91(3):397-399.
356. Basset F, Soler P, Jaurand MC, Bignon J. Ultrastructural examination of broncho-alveolar lavage for diagnosis of pulmonary histiocytosis X: preliminary report on 4 cases. Thorax 1977;32(3):303-306.
357. Nagai S. Pulmonary sarcoidosis: pathogenesis and population differences. Intern Med 1995;34(9):833-838.
358. Vestbo J, Viskum K. Respiratory symptoms at presentation and long-term vital prognosis in patients with pulmonary sarcoidosis. Sarcoidosis 1994;11(2):123-125.
359. Mori PA, Pesci A, Bertorelli G, Anghinolfi M, Strinati F, Barilli F, Olivieri D. The intesity of sarcoidosis alveolitis is related to albumin and IgG levels in BAL. Respiration 1988;54 (Suppl 1:30-35).
360. DeRemee RA. Sarcoidosis. Mayo Clin Proc 1995;70(2):177-181.
361. Line BR, Hunninghake GW, Keogh BA, Jones AE, Johnston GS, Crystal RG. Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. Am Rev Respir Dis 1981;123(4, Part 1):440-446.
362. Rankin JA, Huang SS, Sostman HD, Gee JB, Reynolds HY. An analysis of the inter-relationships among multiple bronchoalveolar lavage and serum determinations, physiologic tests, and clinical disease activity in patients with sarcoidosis. Sarcoidosis 1991;8(1): 19-28.
363. Chretien J, Venet A, Danel C, Israel-Biet D, Sandron D, Arnoux A. Bronchoalveolar lavage in sarcoidosis. Respiration 1985;48(3):222-230.
364. Verstraeten A, Demedts M, Verwilghen J, van den Eeckhout A, Marien G, Lacquet LM, Ceuppens JL. Predictive value of bronchoalveolar lavage in pulmonary sarcoidosis. Chest 1990;98(3):560-567.
365. Dauber JH, Rossman MD, Daniele RP. Bronchoalveolar cell populations in acute sarcoidosis. Observations in smoking and nonsmoking patients. J Lab Clin Med 1979;94(6):862-871.
366. Godard P, Clot J, Jonquet O, Bousquet J, Michel FB. Lymphocyte subpopulations in bronchoalveolar lavages of patients with sarcoidosis and hypersensitivity pneumonitis. Chest 1981;80(4):447-452.
367. Greening AP, Nunn P, Dobson N, Rudolf M, Rees AD. Pulmonary sarcoidosis: alterations in bronchoalveolar lymphocytes and T cell subsets. Thorax 1985;40(4):278-283.
368. Winterbauer RH, Wu R, Springmeyer SC. Fractional analysis of the 120-ml bronchoalveolar lavage. Determination of the best specimen for diagnosis of sarcoidosis. Chest 1993;104(2):344-351.
369. Ceuppens JL, Lacquet LM, Marien G, Demedts M, van den Eeckhout A, Stevens E. Alveolar T-cell subsets in pulmonary sarcoidosis. Correlation with disease activity and effect of steroid treatment. Am Rev Respir Dis 1984;129(4):563-568.
370. Zaman SS, Elshami A, Gupta PK. Bronchoalveolar lavage cytology in pulmonary sarcoidosis. Acta Cytol 1995;39(6):1117-1123.
371. Gruber R, Pforte A, Beer B, Riethmuller G. Determination of gamma/delta and other T-lymphocyte subsets in bronchoalveolar lavage fluid and peripheral blood from patients with sarcoidosis and idiopathic fibrosis of the lung. APMIS 1996;104(3):199-205.
372. Hunninghake GW, Crystal RG. Mechanism of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T-lymphocytes. J Clin Invest 1981;67:86-92.
373. Nowak D, Kanzow D, Kirsten H, Magnussen H. "High intensity alveolitis" in non-smokers and smokers with sarcoidosis. Eur Res J 1991;4 (Suppl):350S.
374. Hunninghake GW, Gadek JE, Young RO Jr, Kawanami O, Ferrans VJ, Crystal RG. Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med 1980;302(11):594-598.
375. Spiteri MA, Johnson M, Epstein O, Sherlock S, Clarke SW, Poulter LW. Immunological features of lung lavage cells from patients with primary biliary cirrhosis may reflect those seen in pulmonary sarcoidosis. Gut;1990;31(2):208-212.
376. Keogh BA, Crystal RG. Alveolitis: the key to the interstitial lung disorders. Thorax 1982;37(1):1-10.
377. Schoenfeld N, Schmitt M, Remy N, Ellensohn P, Loddenkemper R, Wahn U. Activation of bronchoalveolar lavage T lymphocytes and clinical, functional and radiological features in sarcoidosis. Sarcoidosis 1995;12(2):135-139.
378. Bauer W, Gorny MK, Baumann HR, Morell A. T-lymphocyte subsets and immunoglobulin concentrations in bronchoalveolar lavage of patients with sarcoidosis and high and low intensity alveolitis. Am Rev Respir Dis 1985;132(5):1060-1065.
379. Desrues B, Delaval P, Genetet N, Pencole C, Merdrignac G, Dassonville J, et al. Does peripheral blood T-lymphocyte population distribution in sarcoidosis provide a prognostic clue? Sarcoidosis 1991; 8(2):129-133.
380. Tukiainen P, Taskinen E, Riska H. The prognostic value of bronchoalveolar lavage in sarcoidosis. Sarcoidosis 1994;11(1):69-72.
381. Kirks DR, McCormick VD, Greenspan RH. Pulmonary sarcoidosis. Roentgenologic analysis of 150 patients. Am J Roentgenol Radium Ther Nucl Med 1973;117(4):777-786.
382. Remy-Jardin M, Giraud F, Remy J, Wattinne L, Wallaert B, Duhamel A. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 1994;191(3):675-680.
383. Veine NK, Hardt F, Bendixen G, Ringsled J, Brodthagen H, Faber V, et al. Immunological studies in sarcoidosis: a comparison of disease activity and various immunologic parameters. Ann NY Acad Sci 1979;278:47-51.
384. Schoenberger CI, Line BR, Keogh BA, Hunninghake GW, Crystal RG. Lung inflammation in sarcoidosis: comparison of serum angiotensin-converting enzyme levels with bronchoalveolar lavage and gallium-67 scanning assessment of the T-lymphocyte alveolitis. Thorax 1982;37:19-25.
385. Huang ZB, Eden E. Effect of bronchoalveolar lavage fluid from patients with sarcoidosis or AIDS on interleukin 1 beta release from alveolar macrophages. Chest 1990;98(3):576-580.
386. Steffen M, Petersen J, Oldigs M, Karmeier A, Magnussen H, Thiele HG, Raedler A. Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis. J Allergy Clin Immunol 1993;91(4): 939-949.
387. Pueringer RJ, Schwartz DA, Dayton CS, Gilbert SR, Hunninghake GW. The relationship between alveolar macrophage TNF, IL-1, and PGE2 release, alveolitis, and disease activity in sarcoidosis. Chest 1993;103(3):832-838.
388. Homolka J, Muller-Quernheim J. Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis. Lung 1993;171(3):173-183.
389. Striz I, Zheng L, Wang YM, Pokorna H, Bauer PC, Costabel U. Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14. Am J Respir Crit Care Med 1995;151(2, Part 1):544-547.
390. Wait J, Merrill W. Presence of multinucleated giant cells in bronchoalveolar lavage fluid from sarcoid patients. Chest 1982;82 (Suppl): 232S.
391. Roth C, Huchon GJ, Arnoux A, Stanislas-Leguern G, Marsac JH, Chretien J. Bronchoalveolar cells in advanced pulmonary sarcoidosis. Am Rev Respir Dis 1981;124:9-12.
392. Mordelet-Dambrine MS, Stanislas-Leguern GM, Huchon GJ, Baumann FC, Marsac JH, Chretien J. Elevation of the bronchoalveolar concentration of angiotensin I converting enzyme in sarcoidosis. Am Rev Respir Dis 1982;126(3):472-475.
393. Albera C, Marbritto I, Ghio P, Marchetti L, Solidoro P, Pozzi E. Adenosine-deaminase (ADA) in bronchoalveolar fluids and serum in patients with pulmonary sarcoidosis. Eur Respir J 1991;4 (Suppl):299S.
394. Blaschke E, Eklund A, Hernbrand K. Extracellular matrix components in bronchoalveolar lavage fluid in sarcoidosis and their relationship to signs of alveolitis. Am Rev Respir Dis 1990; 141(4, Part 1):1020-1025.
395. Hallgren R, Eklund A, Engstrom-Laurent A, Schmekel B. Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Br Med J Clin Res Ed 1985;290(6484): 1778-1781.
396. Hoogsteden HC, van-Dongen JJ, Adriaansen HJ, Hooijkaas H, Delahaye M, Hop W, Hilvering C. Bronchoalveolar lavage in extrapulmonary sarcoidosis. Chest 1988;94(1):115-118.
397. Wallaert B, Ramon P, Fournier E, Tonnel AB, Voisin C. Bronchoalveolar lavage, serum angiotensin-converting enzyme, and gallium-67 scanning in extrathoracic sarcoidosis. Chest 1982;82(5): 553-555.
398. Salvaggio JE. Diagnosis and management of hypersensitivity pneumonitis. Hosp Pract 1980;15(11):93-96, 101-103.
399. Sharma OP. Hypersensitivity pneumonitis. Dis Mon 1991;37(7): 409-471.
400. Sharma OP, Fujimura N. Hypersensitivity pneumonitis: a noninfectious granulomatosis. Semin Respir Infect 1995;10(2):96-106.
401. Roberts RC, Moore VL. Immunopathogenesis of hypersensitivity pneumonitis. Am Rev Respir Dis 1977;116(6):1075-1090.
402. Schatz M, Patterson R, Fink J. Immunopathogenesis of hypersensitivity pneumonitis. J Allergy Clin Immunol 1977;60(1):27-37.
403. Caldwell JR, Pearce DE, Spencer C, Leder R, Waldman RH. Immunologic mechanisms in hypersensitivity pneumonitis. I. Evidence for cell-mediated immunity and complement fixation in pigeons breeders disease. J Allergy Clin Immunol 1973;52(4):225-230.
404. Yoshizawa Y, Miyashita Y, Inove T, Sumi Y, Miyazaki Y, Sato T, Ohtsuka. Sequential evaluation of clinical and immunological findings in hypersensitivity pneumonitis: serial subclass distribution of antibodies. Clin Immunol Immunopathol 1994;73(3):330-337.
405. Richerson HB, Coon JD, Lubaroff D. Experimental hypersensitivity pneumonitis in the rat: histopathology and T-cell subset compartmentalization. Am J Respir Cell Mol Biol 1991;5(5):451-463.
406. Leatherman JW, Michael AF, Schwartz BA, Hoidal JR. Lung T cells in hypersensitivity pneumonitis. Ann Intern Med 1984;100(3):390-392.
407. Costabel U, Brass KJ, Ruhle KH, Lohr GW, Matthys H. Ia-like antigens on T-cells and their subpopulations in pulmonary sarcoidosis and in hypersensitivity pneumonitis. Analysis of bronchoalveolar and blood lymphocytes. Am Rev Respir Dis 1985;131(3):337-342.
408. Mornex JF, Cordier G, Pages J, Vergnon JM, Lefebure R, Brune J, Revillard JP. Activated lung lymphocytes in hypersensitivity pneumonitis. J Allergy Clin Immunol 1984;74(5):719-727.
409. Hunninghake GW, Kawanami O, Ferrans VJ, Young RC Jr, Roberts WC, Crystal RG. Characterization of inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis 1981;123(4, Part 1):407-412.
410. Bernardo J, Hunninghake GW, Gadek JE, Ferrans VJ, Crystal RG. Acute hypersensitivity pneumonitis: serial changes in lung lymphocyte subpopulations after exposure to antigen. Am Rev Respir Dis 1979;120(5):985-994.
411. Drent M, van Velzen Bald H, Diamant M, Wagenaar SS, Hoogsteden HC, van den Bosch JM. Bronchoalveolar lavage in extrinsic allergic alveolitis: effect of time elapsed since antigen exposure. Eur Respir J 1993;6:1276-1281.
412. Drent M, van Velzen Blad H, Diamant M, Wagenaar SS, Donckerwolck-Bogaert M, van den Bosch JM. Differential diagnosis value of plasma cells in bronchoalveolar lavage fluid. Chest 1993;103(6):1720-1724.
413. Drent M, Wagenaar SS, van Velzen Blad H, Mulder PG, Hoogsteden HC, van den Bosch JM. Relationship between plasma cell levels and profile of bronchoalveolar lavage fluid in patients with subacute extrinsic allergic alveolitis. Thorax 1993;48(8):835-839.
414. Teschler H, Pohl WR, Thompson AB, Konietzko N, Mosher DF, Costabel U, Rennard SI. Elevated levels of bronchoalveolar lavage vitronectin in hypersensitivity pneumonitis. Am Rev Respir Dis 1993;147(2):332-337.
415. Silver RM. Interstitial lung disease of systemic sclerosis. Int Rev Immunol 1995;12(2-4):281-291.
416. Wallaert B, Hatron PY, Grosbois JM, Tonnel AB, Devulder B, Voisin C. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. Am Rev Respir Dis 1986;133(4):574-580.
417. Silver RM, Metcalf JF, Stanley JH, LeRoy EC. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage. Arthritis Rheum 1984;27:1254-1262.
418. Behr J, Vogelmeier C, Beinert T, Meurer M, Krombach F, Konig G, Fruhmann G. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med 1996;154(2, Part 1):400-406.
419. Peters-Golden M, Wise RA, Schneider P, Hochberg M, Stevens MB, Wigley F. Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine Baltimore 1984;63(4):221-231.
420. Silver RM, Miller KS, Kinsella MB, Smith EA, Schabel SI. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med 1990;88(5):470-476.
421. Konig G, Luderschmidt C, Hammer C, Adelmann-Grill BC, Braun-Falco O, Fruhmann G. Lung involvement in scleroderma. Chest 1984;85(3):318-324.
422. Rossi GA, Bitterman PB, Rennard SI, Ferrans VJ, Crystal RG. Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am Rev Respir Dis 1985;131(4):612-617.
423. Anaya JM, Diethelm L, Ortiz LA, Gutierrez M, Citera G, Welsh RA, Espinoza LR. Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 1995;24(4):242-254.
424. Ohhata I, Ochi T, Kurebayashi S, Masutani H, Miyagawa T, Hamagami S, et al. Pulmonary complications in patients with rheumatoid arthritis. Nippon Kyobu Shikkan Gakkai Zasshi 1995;33:101-108.
425. Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B. Lung changes in rheumatoid arthritis. Radiology 1994;193(2):373-382.
426. Garcia JG, Parhami N, Killam D, Garcia PL, Keogh BA. Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis. Am Rev Respir Dis 1986;133(3):450-454.
427. Garcia JG, James HL, Zinkgraf S, Perlman MB, Keogh BA. Lower respiratory tract abnormalities in rheumatoid interstitial lung disease. Potential role of neutrophils in lung injury. Am Rev Respir Dis 1987; 136(4):811-817.
428. Gilligan DM, O'Connor CM, Ward K, Moloney D, Bresnihan B, FitzGerald MX Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease. Thorax 1990;45(8):591-596.
429. Ferdoutsis M, Bouros D, Meletis G, Patsourakis G, Siafakas NM. Diffuse interstitial lung disease as an early manifestation of ankylosing spondylitis. Respiration 1995;62(5):286-289.
430. Wendling D, Dalphin JC, Toson B, Depierre A, Guidet M. Bronchoalveolar lavage in ankylosing spondylitis. Ann Rheum Dis 1990; 49(5):325-326.
431. Hoffman GS, Sechler JM, Gallin JI, Shelhamer JH, Suffredini A, Ognibene FP, et al. Bronchoalveolar lavage analysis in Wegener's granulomatosis. A method to study disease pathogenesis. Am Rev Respir Dis 1991;143(2):401-407.
432. Baltaro RJ, Hoffman GS, Sechler JM, Suffredini AF, Shelhamer JH, Fauci AS, Fleisher TA. Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis. Am Rev Respir Dis 1991;143(2):275-278.
433. Agusti C, Xaubet A, Roca J, Agusti AG, Rodriguez-Roisin R. Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up. Thorax 1992;47(12): 1035-1040.
434. Prin L, Capron M, Gosset P, Wallaert B, Kusnierz JP, Bletry O, et al. Eosinophilic lung disease: immunologic studies of blood and alveolar eosinophils. Clin Exp Immunol 1986;63(1):249-257.
435. Dejaegher P, Demedts M. Bronchoalveolar lavage in eosinophilic pneumonia before and during corticosteroid therapy. Am Rev Respir Dis 1984;129(4):629-632.
436. Schmidt B, Teschler H, Kroegel C, Konietzko N, Mattthyus H, Costabel U. Bronchoalveolar cell profiles in Wegener granulomatosis (WG), chronic eosinophilic pneumonitis (CEP), and Churg-Strauss syndrome (CSS). Eur Respir J 1989;2(Suppl 8), 6415.
437. Allen JN, Davis WB, Pacht ER. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am Rev Respir Dis 1990;142(3):642-647.
438. Pesci A, Bertorelli G, Mangenelli P, Mori PA, Strinati F, Marangio E, et al. Bronchoalveolar lavage in chronic eosinophilic pneumonia. Analysis of six cases in comparison with other interstitial lung diseases. Respiration 1988;54(Suppl):16-22.
439. Olivieri D, Pesci A, Bertorelli G. Eosinophilic alveolitis in immunologic interstitial lung disorders. Lung 1990;168(Suppl):964-973.
440. Grandordy B, Hubert J, Marsac J, Chretien J. Relationship between alveolar eosinophils (AE) and blood eosinophils in bronchopulmonary disease. Am Rev Respir Dis 1983;127:142.
441. Rola-Pleszczynski M, Masse S, Sirois P, Lemaire I, Begin R. Early effects of low-doses exposure to asbestos on local cellular immune responses in the lung. J Immunol 1981;127(6):2535-2538.
442. Begin R, Cantin A, Drapeau G, Lamoureux G, Boctor M, Masse S, Rola-Pleszczynski M. Pulmonary uptake of gallium-67 in asbestos-exposed humans and sheep. Am Rev Respir Dis 1983;127(5):623-630.
443. Gellert AR, Langford JA, Winter RJ, Uthayakumar S, Sinha G, Rudd RM. Asbestosis: assessment by bronchoalveolar lavage and measurement of pulmonary epithelial permeability. Thorax 1985;40(7): 508-514.
444. Wagner JC, Berry G, Skidmore JW, Timbrell V. The effects of the inhalation of asbestos in rats. Br J Cancer 1974;29(3):252-269.
445. Gellert AR, Macey MG, Uthayakumar S, Newland AC, Rudd RM. Lymphocyte subpopulations in bronchoalveolar lavage fluid in asbestos workers. Am Rev Respir Dis 1985;132(4):824-828.
446. Roggli VL, Greenberg SD, McLarty JW, Hurst GA, Hieger LR, Farley ML, Mabry LC. Comparison of sputum and lung asbestos body counts in former asbestos workers. Am Rev Respir Dis 1980;122(6): 941-945.
447. Nair P, Rupawate RU, Prabhakaran LC, Bijur S, Kamat SR. Evaluating computed tomography and broncho alveolar lavage in early diagnosis of pulmonary asbestosis. Sarcoidosis 1991;8(2):115-119.
448. Karjalainen A, Anttila S, Mantyla T, Taskinen E, Kyyronen P, Tukiainen P. Asbestos bodies in bronchoalveolar lavage fluid in relation to occupational history. Am J Ind Med 1994;26(5):645-654.
449. Schwartz DA, Galvin JR, Burmeister LF, Merchant RK, Dayton CS, Merchant JA, Hunninghake GW. The clinical and reliability of asbestos bodies in bronchoalveolar fluid. Am Rev Respir Dis 1991;144(3, Part 1):684-688.
450. De-Vuyst P, Jedwab J, Dumortier P, Vandermoten G, Vande-Weyer R, Yarnault JC. Asbestos bodies in bronchoalveolar lavage. Am Rev Respir Dis 1982;126(6):972-976.
451. Orlowski E, Pairon JC, Ameille J, Janson X, Iwatsubo Y, Dufour G, et al. Pleural plaques, asbestos exposure, and asbestos bodies in bronchoalveolar lavage fluid. Am J Ind Med 1994;26(3):349-358.
452. Occupational silicosis-Ohio. MMWR Morb Mortal Wkly Rep 1995; 44:61-64.
453. Struhar D, Harbeck RJ, Manson RJ. Lymphocyte populations in lung tissue, bronchoalveolar lavage fluid, and peripheral bloods in rat at various times during the development of silicosis. Am Rev Respir Dis 1989;139:28-32.
454. Benson SC, Belton JC, Scheve LG. Regulation of lung fibroblast proliferation and protein synthesis by bronchiolar lavage in experimental silicosis. Environ Res 1986;41(1):61-78.
455. Lapp NL, Castranova V. How silicosis and coal workers' pneumoconiosis develop - a cellular assessment. Occup Med 1993;8(1): 35-56.
456. Saenghirunvattana S, Charoenpan P, Boonpucknavig V, Sriurairatana S, Apibal S. Silicosis in ceramic-industry workers with particular reference to the diagnostic value of bronchoalveolar lavage. J Med Assoc Thai 1991;74(8):358-362.
457. Schuyler MR, Gaumer HR, Stankus RP, Kaimal J, Hoffman E, Salvaggio JE. Bronchoalveolar lavage in silicosis. Lung 1980;157(2): 95-102.
458. Calhoun WJ, Christman JW, Ershler WB, Grahan WG, Davis GS. Raised immunoglobulin concentrations in bronchoalveolar lavage fluid of healthy granite workers. Thorax 1986;41(4):266-273.
459. Begin R, Lesur O, Bouhadiba T, Guojian L, Larivee P, Melloni B, et al. Phospholipid content of bronchoalveolar lavage fluid in granite workers with silicosis in Quebec. Thorax 1993;48(8):840-844.
460. Claypool WD, Rogers RM, Matuschak GM. Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis). Chest 1984;85(4):550-558.
461. Mahut B, Delacour C, Scheinmann P, de Blic J, Mani TM, Fournet JC, Bellon G. Pulmonary alveolar proteinosis: experience with eight pediatric cases and a review. Pediatrics 1996;97(1):117-122.
462. Martin RJ, Rogers RM, Myers NM. Pulmonary alveolar proteinosis: shunt fraction and lactic acid dehydrogenase concentration as aids to diagnosis. Am Rev Respir Dis 1978;117(6):1059-1062.
463. Hoffman RM, Rogers RM. Serum and lavage lactate dehydrogenase isoenzymes in pulmonary alveolar proteinosis. Am Rev Respir Dis 1991;143(1):42-46.
464. Hook GE, Bell DY, Gilmore LB, Nadeau D, Reasor MJ, Talley FA. Composition of bronchoalveolar lavage effluents from patients with pulmonary alveolar proteinosis. Lab Invest 1978;39(4):342-357.
465. Milleron BJ, Costabel U, Teschler H, Ziesche R, Cadranel JL, Matthys H, Akoun GM. Bronchoalveolar lavage cell data in alveolar proteinosis. Am Rev Respir Dis 1991;144(6):1330-1332.
466. Bell DY, Hook GE. Pulmonary alveolar proteinosis: analysis of airway and alveolar proteins. Am Rev Respir Dis 1979; 119(6):979-990.
467. Prakash UB, Barham SS, Carpenter HA, Dines DE, Marsh HM. Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc 1987;62(6):499-518.
468. Sahu S, DiAugustine RP, Lynn WS. Lipids found in pulmonary lavage of patients with alveolar proteinosis and in rabbit lung lamellar organelles. Am Rev Respir Dis 1976;114(1):177-185.
469. Harris JO, Castle JR, Swenson EW, Block AJ. Lobar lavage: therapeutic benefit in pulmonary alveolar filling disorders. Chest 1974;65(6):655-659.
470. Du Bois RM, McAllister WA, Branthwaite MA. Alveolar proteinosis: diagnosis and treatment over a 10-year period. Thorax 1983;38(5): 360-363.
471. Brach BB, Harrel JH, Moser KM. Alveolar proteinosis: lobar lavage by fiberoptic bronchoscopic technique. Chest 1976;69(2):224-227.